UBS AM’s HCA Healthcare HCA Stock Holding History

UBS AM’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$710M	Sell	1,500,000 -59,356	-4%	-$29.9M	0.15%	126
2025 Q4	$728M	Sell	1,559,356 -157,059	-9%	-$72.9M	0.15%	115
2025 Q3	$732M	Sell	1,716,415 -250,960	-13%	-$97.3M	0.16%	114
2025 Q2	$754M	Buy	1,967,375 +307,728	+19%	+$111M	0.15%	125
2025 Q1	$573M	Sell	1,659,647 -15,813	-0.9%	-$5.09M	0.15%	143
2024 Q4	$503M	Buy	1,675,460 +188,093	+13%	+$65.7M	0.12%	156
2024 Q3	$605M	Buy	1,487,367 +41,190	+3%	+$15.1M	0.16%	119
2024 Q2	$465M	Buy	1,446,177 +275,246	+24%	+$89.4M	0.13%	129
2024 Q1	$391M	Sell	1,170,931 -120,332	-9%	-$36.8M	0.14%	146
2023 Q4	$350M	Buy	1,291,263 +7,770	+0.6%	+$1.92M	0.14%	147
2023 Q3	$316M	Buy	1,283,493 +100,203	+8%	+$27.4M	0.14%	145
2023 Q2	$312M	Hold	1,183,290	–	–	0.15%	139
2023 Q1	$312M	Sell	1,183,290 -91,740	-7%	-$23.3M	0.15%	139
2022 Q4	$306M	Sell	1,275,030 -47,217	-4%	-$10.6M	0.16%	137
2022 Q3	$243M	Sell	1,322,247 -136,633	-9%	-$27.2M	0.14%	160
2022 Q2	$245M	Buy	1,458,880 +198	+0%	+$42.5K	0.13%	171
2022 Q1	$366M	Buy	1,458,682 +13,862	+1%	+$3.48M	0.16%	129
2021 Q4	$371M	Buy	1,444,820 +54,557	+4%	+$13.4M	0.14%	153
2021 Q3	$337M	Buy	1,390,263 +9,319	+0.7%	+$2.28M	0.14%	157
2021 Q2	$285M	Sell	1,380,944 -92,362	-6%	-$18.8M	0.12%	176
2021 Q1	$277M	Buy	1,473,306 +12,574	+0.9%	+$2.22M	0.12%	174
2020 Q4	$240M	Buy	1,460,732 +11,540	+0.8%	+$1.69M	0.11%	179
2020 Q3	$181M	Buy	1,449,192 +185,477	+15%	+$23M	0.1%	202
2020 Q2	$123M	Sell	1,263,715 -68,782	-5%	-$7.15M	0.07%	260
2020 Q1	$120M	Buy	1,332,497 +55,300	+4%	+$7.16M	0.09%	230
2019 Q4	$189M	Buy	1,277,197 +4,544	+0.4%	+$610K	0.12%	188
2019 Q3	$153M	Sell	1,272,653 -37,625	-3%	-$4.86M	0.1%	212
2019 Q2	$177M	Sell	1,310,278 -514,819	-28%	-$65.1M	0.13%	176
2019 Q1	$238M	Sell	1,825,097 -66,955	-4%	-$8.99M	0.18%	115
2018 Q4	$235M	Buy	1,892,052 +691,284	+58%	+$92.8M	0.2%	101
2018 Q3	$167M	Sell	1,200,768 -283,597	-19%	-$35.3M	0.12%	186
2018 Q2	$152M	Buy	1,484,365 +411,139	+38%	+$41.6M	0.12%	203
2018 Q1	$104M	Sell	1,073,226 -99,741	-9%	-$9.68M	0.08%	280
2017 Q4	$103M	Sell	1,172,967 -46,299	-4%	-$3.72M	0.09%	262
2017 Q3	$97M	Buy	1,219,266 +19,205	+2%	+$1.54M	0.09%	255
2017 Q2	$105M	Sell	1,200,061 -658,052	-35%	-$55.7M	0.1%	239
2017 Q1	$165M	Buy	1,858,113 +101,837	+6%	+$8.49M	0.17%	133
2016 Q4	$130M	Sell	1,756,276 -185,977	-10%	-$13.9M	0.15%	158
2016 Q3	$147M	Sell	1,942,253 -196,875	-9%	-$15.1M	0.16%	147
2016 Q2	$165M	Sell	2,139,128 -226,882	-10%	-$17.9M	0.19%	121
2016 Q1	$185M	Sell	2,366,010 -461,500	-16%	-$32.2M	0.21%	106
2015 Q4	$191M	Sell	2,827,510 -1,008,217	-26%	-$70.3M	0.22%	95
2015 Q3	$297M	Sell	3,835,727 -104,990	-3%	-$9.3M	0.33%	68
2015 Q2	$358M	Sell	3,940,717 -52,044	-1%	-$4.17M	0.34%	65
2015 Q1	$300M	Buy	3,992,761 +653,197	+20%	+$46.9M	0.29%	74
2014 Q4	$245M	Buy	3,339,564 +75,541	+2%	+$5.31M	0.23%	98
2014 Q3	$230M	Sell	3,264,023 -261,471	-7%	-$17.3M	0.23%	99
2014 Q2	$199M	Buy	3,525,494 +322,173	+10%	+$17M	0.2%	121
2014 Q1	$168M	Buy	3,203,321 +2,313,864	+260%	+$115M	0.18%	136
2013 Q4	$42.4M	Buy	889,457 +108,587	+14%	+$5.02M	0.05%	392
2013 Q3	$33.4M	Sell	780,870 -6,534	-0.8%	-$255K	0.04%	442
2013 Q2	$28.4M	Buy	+787,404	New	+$30.5M	0.04%	476